Back to Search
QUE CHU, MD
MD
Pediatrics Physician
NPI: 1750358768Individual
Specialties, Licenses & Credentials
Anesthesiology Physician
Anesthesiology
Code: 207L00000X
A43191(CA)
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
ME98320(FL)
Research & Publications (20)
High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
PMID 19500800·J Surg Res·2010
8-other
Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors.
PMID 19236257·Expert Opin Biol Ther·2009
6-review
Antitumor potential of three herbal extracts against human oral squamous cell lines.
PMID 19661337·Anticancer Res·2009
8-other
[Influence of transfection with human transforming growth factor-beta1 gene on the osteogenic potential of the cultured human gingival fibroblast].
PMID 19637473·Hua Xi Kou Qiang Yi Xue Za Zhi·2009
8-other
[Effects of gingival fibroblasts transfected with human transform growth factor-beta1 gene on improving the periodontal tissue regeneration].
PMID 19575983·Zhonghua Kou Qiang Yi Xue Za Zhi·2009
7-preclinical
Astrocytes facilitate the growth and differentiation of co-cultured mesenchymal stem cells.
PMID 18563335·J Huazhong Univ Sci Technolog Med Sci·2008
7-preclinical
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
PMID 18628463·Clin Cancer Res·2008
3-trial
Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir.
PMID 17950092·J Surg Res·2007
7-preclinical
S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
PMID 17155983·BJU Int·2007
7-preclinical
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
PMID 17237909·Invest New Drugs·2007
3-trial
Syntheses, structures, and optical properties of novel zinc(ii) complexes with multicarboxylate and N-donor ligands.
PMID 17893820·Dalton Trans·2007
8-other
Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism.
PMID 17383716·Pharmacol Biochem Behav·2007
7-preclinical
Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies.
PMID 17704424·J Clin Oncol·2007
3-trial
Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center.
PMID 16553132·Am Surg·2006
4-observational
A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
PMID 16675472·Carcinogenesis·2006
8-other
Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
PMID 16139391·Lung Cancer·2005
6-review
Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis.
PMID 15538115·Diagn Mol Pathol·2004
8-other
Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.
PMID 15297391·Clin Cancer Res·2004
3-trial
Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography.
PMID 15222041·World J Gastroenterol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2400 E 4TH ST
NATIONAL CITY, CA 91950 - Phone
- (850) 576-4073
Quick Facts
- NPI
- 1750358768
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile